(VIANEWS) – IBERSOL,SGPS (IBS.LS), PROXIMUS (PROX.BR), INTERPARFUMS (ITP.PA) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. IBERSOL,SGPS (IBS.LS)
159.19% Payout Ratio
Earnings Per Share
As for profitability, IBERSOL,SGPS has a trailing twelve months EPS of €0.48.
PE Ratio
IBERSOL,SGPS has a trailing twelve months price to earnings ratio of 14.75. Meaning, the purchaser of the share is investing €14.75 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.28%.
Sales Growth
IBERSOL,SGPS’s sales growth is negative 64.7% for the present quarter and negative 0.7% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
IBERSOL,SGPS’s EBITDA is 13.3.
Moving Average
IBERSOL,SGPS’s worth is higher than its 50-day moving average of €6.63 and higher than its 200-day moving average of €6.80.
More news about IBERSOL,SGPS.
2. PROXIMUS (PROX.BR)
108.11% Payout Ratio
Proximus PLC provides digital services and communication solutions in Belgium and internationally. It operates through Domestic, International Carrier Services, and TeleSign segments. The company offers fixed and mobile telephony, internet, and television services to residential customers and small businesses, and ICT services to residential, business, and telecom wholesale markets. It also provides managed and platform, integrating networking, cloud, cybersecurity, business application, and data and artificial intelligence services. In addition, the company offers international delivery authentication and digital identity services to internet brands, digital champions, and cloud native businesses. It offers its products and services under Proximus, Scarlet, Mobile Vikings, Tango, Telindus, and Telindus Netherlands brands. The company was formerly known as Belgacom SA and changed its name to Proximus PLC in June 2015. The company was founded in 1930 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, PROXIMUS has a trailing twelve months EPS of €1.11.
PE Ratio
PROXIMUS has a trailing twelve months price to earnings ratio of 6.26. Meaning, the purchaser of the share is investing €6.26 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.8%.
Moving Average
PROXIMUS’s worth is under its 50-day moving average of €7.70 and way under its 200-day moving average of €7.90.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 24, 2024, the estimated forward annual dividend rate is 1.4 and the estimated forward annual dividend yield is 19%.
More news about PROXIMUS.
3. INTERPARFUMS (ITP.PA)
53.03% Payout Ratio
Interparfums SA designs, manufactures, and distributes perfumes through license agreements with ready-to-wear, jewelry, or accessories houses in France and internationally. The company operates through Perfumes and Fashion segments. It serves customers under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Montblanc, Moncler, Rochas, S.T. Dupont, Van Cleef & Arpels, and other brand names. The company distributes its products through wholly owned distribution subsidiaries or joint ventures, independent companies, subsidiaries of luxury good corporations, and duty-free operators. Interparfums SA was founded in 1982 and is headquartered in Paris, France. Interparfums SA operates as a subsidiary of Inter Parfums, Inc.
Earnings Per Share
As for profitability, INTERPARFUMS has a trailing twelve months EPS of €1.8.
PE Ratio
INTERPARFUMS has a trailing twelve months price to earnings ratio of 29. Meaning, the purchaser of the share is investing €29 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.33%.
More news about INTERPARFUMS.
4. GIMV (GIMB.BR)
40.56% Payout Ratio
Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer 2020; Connected Consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer 2020, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. It mainly focuses on European market and midcap companies in Flanders and Brussels, and also invests in Kazakhstan, Benelux, Germany, France, Italy, Luxembourg, Netherlands, United Kingdom, Russia, Czech Republic, and Slovakia. Within consumer 2020, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. It invests in small and medium sized businesses primarily with headquarters in the Benelux, France, and Germany with an enterprise value of up to €125 million ($144.76 million). Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies with headquarters in Benelux, France and DACH region. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced computation power, and components and systems for efficient use of energy, in terms of production, storage, management, use and transport sectors. It focuses on B2B products and services, based on innovation, advanced engineering, advanced manufacturing or software. It also makes flexible equity investment (equity, semi-equity, minority or majority) but always with a meaningful impact on the company and an exit trigger. Within sustainable cities, it focuses on Products, services and infrastructure for building sustainable urban societies: Utilities and consumer goods related to energy and other (raw) materials, Waste treatment, recycling and recovery, Construction and Infrastructure, Transport and Logistics Services, and biomass, green (sustainable) chemistry, water, offshore and maritime solutions and energy efficient infrastructure. It invests through (mezzanine, equity, minority or majority) but will always strive to have a meaningful impact on the company strategy and need an exit trigger. It also invests in semiconductors, chemicals, agriculture, clean technology, electronics, water processing and purification technologies. It seeks to invest in small to medium companies with headquarters in the Benelux, France and Germany (DACH) targeting an international customer base. For fund of fund investments, it seeks to invest in Europe. It seeks to invest between €2.5 million ($2.90 million) to €300 million ($425.44 million) with an enterprise value between $86.85 million and $868.55 million and sales value ranging from €5 million ($6.67 million) million to €400 million ($567.25 million). It typically makes investments between €3 million ($3.47 million) to €10 million ($11.58 million) in the biopharma and MedTech and between €10 million ($11.58 million) to €30 million ($34.74 million) in the health and care services. It may take a majority or a minority stake in its portfolio companies. Its investment horizon is between four and seven years. It also seeks a board seat in its portfolio companies. It invests with capital from its own balance sheet and through various funds under management. Gimv NV was founded on February 25, 1980 and is based in Antwerp, Belgium with additional offices in Paris, France; Hague, The Netherlands; Frankfurt am Main, Germany; London, United Kingdom; Prague, Czech Republic; Warsaw, Poland; and Munich, Germany.
Earnings Per Share
As for profitability, GIMV has a trailing twelve months EPS of €6.41.
PE Ratio
GIMV has a trailing twelve months price to earnings ratio of 6.94. Meaning, the purchaser of the share is investing €6.94 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.99%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jul 3, 2023, the estimated forward annual dividend rate is 2.6 and the estimated forward annual dividend yield is 5.8%.
More news about GIMV.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of €1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
More news about 1.
